Focus Partners Wealth

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1542153 ST LOUIS, MO

Position in REGN

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$8,756,372

-$3,946,602 QoQ

Shares Held

14,043

-14.6% QoQ

Ownership

0.014%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#313

of 1,322 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 32% Shared 0% None 68%

Healthcare · as of Jun 30, 2026

Focus Partners Wealth holds $223,220,139 across 78 Biotechnology names. REGN ranks #7 (3.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	128,958	$64,057,307
2	CELC	Celcuity Inc.	232,559	$24,330,322
3	ABVX	Abivax S.A.	161,874	$21,571,329
4	INCY	Incyte Corp	161,917	$18,354,911
5	HALO	Halozyme Therapeutics, Inc.	163,036	$12,760,827
6	IONS	Ionis Pharmaceuticals Inc	147,917	$11,728,338
7	REGN	Regeneron Pharmaceuticals, Inc. This page	14,043	$8,756,372
8	EXEL	Exelixis, Inc.	112,673	$6,130,537

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,756,372	14,043	-14.6%	Shares	Sole	2026-08-12
2026-03-31	$12,702,974	16,441	+38.1%	Shares	Sole	2026-05-15
2025-12-31	$9,189,884	11,906	+30.1%	Shares	Sole	2026-02-13
2025-09-30	$5,145,895	9,152	+70.5%	Shares	Sole	2025-11-14
2025-06-30	$2,817,675	5,367	-9.7%	Shares	Sole	2025-08-14
2025-03-31	$3,771,131	5,946	-35.3%	Shares	Sole	2025-05-20
2024-12-31	$6,542,038	9,184	+209.1%	Shares	Sole	2025-05-20
2024-09-30	$3,123,234	2,971	-56.9%	Shares	Sole	2024-11-14
2024-06-30	$7,244,749	6,893	+38.1%	Shares	Sole	2024-08-15
2024-03-31	$4,805,712	4,993	+86.7%	Shares	Sole	2024-05-16
2023-12-31	$2,348,547	2,674	—	Shares	Sole	2024-02-15
No filing history on record for this holder in this stock.